Loading clinical trials...
Loading clinical trials...
LEO 27847 - Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in Secondary Hyperparathyroidism Patients With Chronic Kidney Disease
Conditions
Interventions
LEO 27847
Locations
2
Germany
CRS Clinical Research Services Kiel GmbH
Kiel, Germany
Centralny Szpital Kliniczny MON
Warsaw, Poland
Start Date
June 1, 2010
Primary Completion Date
October 1, 2011
Completion Date
December 1, 2011
Last Updated
February 24, 2025
NCT03633708
NCT04922892
NCT06434961
NCT04064827
NCT02859896
NCT00415584
Lead Sponsor
LEO Pharma
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions